| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.25e-11 | 46 | 47 | 7 | GO:0030020 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.22e-08 | 188 | 47 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | collagen binding | 3.92e-05 | 81 | 47 | 4 | GO:0005518 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL4A2 HSPG2 COL6A1 MRPL20 COL6A2 COL11A2 COL13A1 COL5A3 COL22A1 | 1.99e-04 | 891 | 47 | 9 | GO:0005198 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL4A2 HSPG2 COL6A1 COL11A2 SULF2 COL13A1 COL5A3 COL22A1 MMP15 | 2.68e-07 | 377 | 50 | 9 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL4A2 HSPG2 COL6A1 COL11A2 SULF2 COL13A1 COL5A3 COL22A1 MMP15 | 2.74e-07 | 378 | 50 | 9 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL4A2 HSPG2 COL6A1 COL11A2 SULF2 COL13A1 COL5A3 COL22A1 MMP15 | 2.80e-07 | 379 | 50 | 9 | GO:0045229 |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 2.19e-05 | 354 | 50 | 7 | GO:0050769 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 2.24e-05 | 819 | 50 | 10 | GO:0120039 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 2.41e-05 | 826 | 50 | 10 | GO:0048858 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | COL4A2 HSPG2 NOG MAP6 PTPRZ1 SP6 TRPV2 DBN1 RREB1 MAP2K1 MARCKS | 4.76e-05 | 1090 | 50 | 11 | GO:0022603 |
| GeneOntologyBiologicalProcess | axonogenesis | 5.95e-05 | 566 | 50 | 8 | GO:0007409 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 6.29e-05 | 418 | 50 | 7 | GO:0051962 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 6.82e-05 | 748 | 50 | 9 | GO:0048667 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | HSPG2 COL6A1 BCL11B NOG MAP6 PTPRZ1 TRPV2 DBN1 RREB1 MAP2K1 MARCKS | 1.08e-04 | 1194 | 50 | 11 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 1.16e-04 | 802 | 50 | 9 | GO:0048812 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 1.19e-04 | 625 | 50 | 8 | GO:0051960 | |
| GeneOntologyBiologicalProcess | axon development | 1.43e-04 | 642 | 50 | 8 | GO:0061564 | |
| GeneOntologyBiologicalProcess | positive regulation of Schwann cell migration | 1.60e-04 | 8 | 50 | 2 | GO:1900149 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 1.68e-04 | 114 | 50 | 4 | GO:0050772 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 1.77e-04 | 494 | 50 | 7 | GO:0031346 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 2.29e-04 | 515 | 50 | 7 | GO:0050767 | |
| GeneOntologyBiologicalProcess | cartilage development | 3.00e-04 | 243 | 50 | 5 | GO:0051216 | |
| GeneOntologyBiologicalProcess | regulation of oligodendrocyte progenitor proliferation | 3.74e-04 | 12 | 50 | 2 | GO:0070445 | |
| GeneOntologyBiologicalProcess | oligodendrocyte progenitor proliferation | 4.42e-04 | 13 | 50 | 2 | GO:0070444 | |
| GeneOntologyBiologicalProcess | regulation of Schwann cell migration | 4.42e-04 | 13 | 50 | 2 | GO:1900147 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 4.51e-04 | 410 | 50 | 6 | GO:0031589 | |
| GeneOntologyBiologicalProcess | Schwann cell migration | 5.14e-04 | 14 | 50 | 2 | GO:0036135 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 6.58e-04 | 614 | 50 | 7 | GO:0010720 | |
| GeneOntologyBiologicalProcess | positive regulation of glial cell migration | 7.65e-04 | 17 | 50 | 2 | GO:1903977 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 8.32e-04 | 76 | 50 | 3 | GO:0030199 | |
| GeneOntologyBiologicalProcess | lung morphogenesis | 8.64e-04 | 77 | 50 | 3 | GO:0060425 | |
| GeneOntologyBiologicalProcess | neuron projection development | 8.86e-04 | 1285 | 50 | 10 | GO:0031175 | |
| GeneOntologyCellularComponent | collagen trimer | 1.58e-09 | 88 | 50 | 7 | GO:0005581 | |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A2 HSPG2 COL6A1 COL6A2 COL11A2 COL13A1 PTPRZ1 COL5A3 COL22A1 MMP15 PKHD1L1 | 3.38e-07 | 658 | 50 | 11 | GO:0030312 |
| GeneOntologyCellularComponent | extracellular matrix | COL4A2 HSPG2 COL6A1 COL6A2 COL11A2 COL13A1 PTPRZ1 COL5A3 COL22A1 MMP15 | 2.86e-06 | 656 | 50 | 10 | GO:0031012 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A2 HSPG2 COL6A1 COL6A2 COL11A2 COL13A1 PTPRZ1 COL5A3 COL22A1 | 4.02e-06 | 530 | 50 | 9 | GO:0062023 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.33e-05 | 332 | 50 | 7 | GO:0005788 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 1.66e-05 | 21 | 50 | 3 | GO:0098644 | |
| GeneOntologyCellularComponent | axon | 2.32e-04 | 891 | 50 | 9 | GO:0030424 | |
| GeneOntologyCellularComponent | SNARE complex | 2.47e-04 | 51 | 50 | 3 | GO:0031201 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 3.64e-04 | 12 | 50 | 2 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 3.64e-04 | 12 | 50 | 2 | GO:0098643 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL4A2 COL6A1 COL11A2 MAP6 KIF28P COL5A3 DBN1 KLC4 MAP2K1 MARCKS | 4.30e-04 | 1187 | 50 | 10 | GO:0099081 |
| GeneOntologyCellularComponent | distal axon | 5.75e-04 | 435 | 50 | 6 | GO:0150034 | |
| GeneOntologyCellularComponent | supramolecular fiber | 1.73e-03 | 1179 | 50 | 9 | GO:0099512 | |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 1.76e-03 | 26 | 50 | 2 | GO:0099571 | |
| GeneOntologyCellularComponent | synaptic membrane | 2.57e-03 | 583 | 50 | 6 | GO:0097060 | |
| GeneOntologyCellularComponent | dendritic spine | 2.66e-03 | 242 | 50 | 4 | GO:0043197 | |
| GeneOntologyCellularComponent | growth cone | 2.78e-03 | 245 | 50 | 4 | GO:0030426 | |
| GeneOntologyCellularComponent | neuron spine | 2.86e-03 | 247 | 50 | 4 | GO:0044309 | |
| GeneOntologyCellularComponent | basement membrane | 3.11e-03 | 122 | 50 | 3 | GO:0005604 | |
| GeneOntologyCellularComponent | site of polarized growth | 3.12e-03 | 253 | 50 | 4 | GO:0030427 | |
| GeneOntologyCellularComponent | axonal growth cone | 5.20e-03 | 45 | 50 | 2 | GO:0044295 | |
| GeneOntologyCellularComponent | kinesin complex | 6.14e-03 | 49 | 50 | 2 | GO:0005871 | |
| GeneOntologyCellularComponent | microtubule associated complex | 6.74e-03 | 161 | 50 | 3 | GO:0005875 | |
| HumanPheno | Spinal rigidity | 2.66e-05 | 59 | 16 | 4 | HP:0003306 | |
| HumanPheno | Waddling gait | 3.49e-05 | 130 | 16 | 5 | HP:0002515 | |
| HumanPheno | Quadriceps muscle weakness | 4.33e-05 | 23 | 16 | 3 | HP:0003731 | |
| HumanPheno | Reduced muscle collagen VI | 5.53e-05 | 4 | 16 | 2 | HP:0030095 | |
| HumanPheno | Curved toe phalanx | 5.53e-05 | 4 | 16 | 2 | HP:0010176 | |
| HumanPheno | Reduced maximal expiratory pressure | 5.53e-05 | 4 | 16 | 2 | HP:0012497 | |
| HumanPheno | Increased laxity of fingers | 9.20e-05 | 5 | 16 | 2 | HP:0006149 | |
| HumanPheno | Strabismus | COL4A2 HSPG2 COL6A1 COL6A2 COL11A2 COL13A1 NOG DHX37 HADHA RREB1 MAP2K1 | 1.12e-04 | 1159 | 16 | 11 | HP:0000486 |
| HumanPheno | Abnormal conjugate eye movement | COL4A2 HSPG2 COL6A1 COL6A2 COL11A2 COL13A1 NOG DHX37 HADHA RREB1 MAP2K1 | 1.55e-04 | 1198 | 16 | 11 | HP:0000549 |
| HumanPheno | Keratosis pilaris | 1.85e-04 | 37 | 16 | 3 | HP:0032152 | |
| HumanPheno | Wrist hypermobility | 1.92e-04 | 7 | 16 | 2 | HP:0005072 | |
| HumanPheno | Abnormality of the cervical spine | 1.94e-04 | 439 | 16 | 7 | HP:0003319 | |
| HumanPheno | Wrist flexion contracture | 2.01e-04 | 38 | 16 | 3 | HP:0001239 | |
| HumanPheno | Lumbar hyperlordosis | 2.04e-04 | 99 | 16 | 4 | HP:0002938 | |
| HumanPheno | Distal joint hypermobility | 3.29e-04 | 9 | 16 | 2 | HP:0020152 | |
| HumanPheno | Abnormality of the neck | 3.88e-04 | 858 | 16 | 9 | HP:0000464 | |
| HumanPheno | Cigarette-paper scars | 4.10e-04 | 10 | 16 | 2 | HP:0001073 | |
| HumanPheno | Axial muscle weakness | 4.56e-04 | 50 | 16 | 3 | HP:0003327 | |
| HumanPheno | Shoulder contracture | 5.00e-04 | 11 | 16 | 2 | HP:0034665 | |
| HumanPheno | Abnormal axial muscle morphology | 5.12e-04 | 52 | 16 | 3 | HP:0040286 | |
| HumanPheno | Flexion contracture of finger | 6.34e-04 | 240 | 16 | 5 | HP:0005651 | |
| HumanPheno | Camptodactyly (hands) | 6.34e-04 | 240 | 16 | 5 | HP:0010563 | |
| HumanPheno | Joint contractures involving the joints of the feet | 6.34e-04 | 240 | 16 | 5 | HP:0100492 | |
| HumanPheno | Camptodactyly of finger | 6.34e-04 | 240 | 16 | 5 | HP:0100490 | |
| HumanPheno | Interphalangeal joint contracture of finger | 6.34e-04 | 240 | 16 | 5 | HP:0001220 | |
| HumanPheno | Camptodactyly of toe | 6.34e-04 | 240 | 16 | 5 | HP:0001836 | |
| HumanPheno | Flexion contracture of toe | 6.34e-04 | 240 | 16 | 5 | HP:0005830 | |
| HumanPheno | Toe joint contracture | 6.46e-04 | 241 | 16 | 5 | HP:0034675 | |
| HumanPheno | Generalized muscle weakness | 6.52e-04 | 134 | 16 | 4 | HP:0003324 | |
| HumanPheno | Lower limb muscle weakness | 6.84e-04 | 244 | 16 | 5 | HP:0007340 | |
| HumanPheno | Frequent falls | 7.49e-04 | 139 | 16 | 4 | HP:0002359 | |
| HumanPheno | Joint dislocation | 8.01e-04 | 390 | 16 | 6 | HP:0001373 | |
| HumanPheno | Flexion contracture of finger | 8.68e-04 | 257 | 16 | 5 | HP:0012785 | |
| HumanPheno | Short neck | 8.92e-04 | 398 | 16 | 6 | HP:0000470 | |
| HumanPheno | Finger joint contracture | 8.99e-04 | 259 | 16 | 5 | HP:0034681 | |
| HumanPheno | Respiratory failure | 9.47e-04 | 262 | 16 | 5 | HP:0002878 | |
| HumanPheno | Abnormal phalangeal joint morphology of the hand | 9.47e-04 | 262 | 16 | 5 | HP:0006261 | |
| HumanPheno | Short 5th metacarpal | 9.48e-04 | 15 | 16 | 2 | HP:0010047 | |
| HumanPheno | Muscle fiber necrosis | 9.48e-04 | 15 | 16 | 2 | HP:0003713 | |
| HumanPheno | Abnormal neck morphology | 1.05e-03 | 766 | 16 | 8 | HP:0025668 | |
| HumanPheno | Aplasia/Hypoplasia of the 5th metacarpal | 1.08e-03 | 16 | 16 | 2 | HP:0010045 | |
| HumanPheno | Hypoplastic ischia | 1.08e-03 | 16 | 16 | 2 | HP:0003175 | |
| Domain | Collagen | 1.99e-09 | 85 | 48 | 7 | PF01391 | |
| Domain | Collagen | 1.99e-09 | 85 | 48 | 7 | IPR008160 | |
| Domain | Laminin_G | 1.47e-05 | 58 | 48 | 4 | IPR001791 | |
| Domain | TSPN | 2.72e-05 | 23 | 48 | 3 | SM00210 | |
| Domain | Synaphin | 3.87e-05 | 4 | 48 | 2 | IPR008849 | |
| Domain | Synaphin | 3.87e-05 | 4 | 48 | 2 | PF05835 | |
| Domain | Laminin_G_2 | 1.47e-04 | 40 | 48 | 3 | PF02210 | |
| Domain | LamG | 1.96e-04 | 44 | 48 | 3 | SM00282 | |
| Domain | NC1_FIB | 3.51e-04 | 11 | 48 | 2 | PS51461 | |
| Domain | Fib_collagen_C | 3.51e-04 | 11 | 48 | 2 | IPR000885 | |
| Domain | Fib_collagen_C | 3.51e-04 | 11 | 48 | 2 | PD002078 | |
| Domain | COLFI | 3.51e-04 | 11 | 48 | 2 | SM00038 | |
| Domain | COLFI | 3.51e-04 | 11 | 48 | 2 | PF01410 | |
| Domain | VWA | 4.01e-04 | 56 | 48 | 3 | PF00092 | |
| Domain | - | 9.09e-04 | 74 | 48 | 3 | 3.40.50.410 | |
| Domain | VWFA | 1.22e-03 | 82 | 48 | 3 | PS50234 | |
| Domain | VWA | 1.31e-03 | 84 | 48 | 3 | SM00327 | |
| Domain | - | 1.87e-03 | 95 | 48 | 3 | 2.60.120.200 | |
| Domain | VWF_A | 2.10e-03 | 99 | 48 | 3 | IPR002035 | |
| Domain | ConA-like_dom | 2.39e-03 | 219 | 48 | 4 | IPR013320 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 5.21e-12 | 41 | 34 | 7 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 8.84e-12 | 44 | 34 | 7 | M27812 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 3.50e-11 | 53 | 34 | 7 | MM14566 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 9.78e-11 | 61 | 34 | 7 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.39e-10 | 64 | 34 | 7 | M26953 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.93e-10 | 67 | 34 | 7 | M26999 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 4.78e-10 | 76 | 34 | 7 | MM14573 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.13e-09 | 140 | 34 | 8 | M587 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.60e-09 | 90 | 34 | 7 | M631 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 8.44e-09 | 114 | 34 | 7 | MM14571 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A2 HSPG2 COL6A1 COL6A2 COL11A2 COL13A1 COL5A3 COL22A1 MMP15 | 2.61e-08 | 300 | 34 | 9 | M610 |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 4.40e-08 | 84 | 34 | 6 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.72e-08 | 85 | 34 | 6 | M16441 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.18e-07 | 50 | 34 | 5 | MM14796 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.33e-07 | 20 | 34 | 4 | MM15061 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.36e-07 | 258 | 34 | 8 | MM14572 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 3.24e-07 | 61 | 34 | 5 | M27103 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 9.82e-07 | 76 | 34 | 5 | M27219 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 9.82e-07 | 76 | 34 | 5 | MM14867 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.96e-06 | 38 | 34 | 4 | MM14969 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.96e-06 | 42 | 34 | 4 | M7169 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 3.26e-06 | 43 | 34 | 4 | M39565 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 4.28e-06 | 46 | 34 | 4 | M198 | |
| Pathway | KEGG_FOCAL_ADHESION | 7.10e-06 | 199 | 34 | 6 | M7253 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.02e-05 | 57 | 34 | 4 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.09e-05 | 58 | 34 | 4 | M2049 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.17e-05 | 59 | 34 | 4 | M27218 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.52e-05 | 63 | 34 | 4 | M11187 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 2.88e-05 | 74 | 34 | 4 | M160 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 5.15e-05 | 418 | 34 | 7 | MM15587 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 6.06e-05 | 32 | 34 | 3 | MM14924 | |
| Pathway | WP_FOCAL_ADHESION | 7.93e-05 | 187 | 34 | 5 | MM15913 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.93e-04 | 47 | 34 | 3 | MM14925 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.32e-04 | 532 | 34 | 7 | M27870 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 3.73e-04 | 575 | 34 | 7 | M29853 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 3.75e-04 | 261 | 34 | 5 | MM15676 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 5.29e-04 | 66 | 34 | 3 | M18 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 5.82e-04 | 161 | 34 | 4 | M39770 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 7.29e-04 | 302 | 34 | 5 | M39719 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 9.41e-04 | 19 | 34 | 2 | MM15512 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.03e-03 | 326 | 34 | 5 | MM15917 | |
| Pathway | WP_FOCAL_ADHESION | 1.28e-03 | 199 | 34 | 4 | M39402 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 2.05e-03 | 28 | 34 | 2 | MM15957 | |
| Pathway | KEGG_THYROID_CANCER | 2.20e-03 | 29 | 34 | 2 | M523 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.35e-03 | 30 | 34 | 2 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.35e-03 | 30 | 34 | 2 | M27216 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.35e-03 | 30 | 34 | 2 | MM15517 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 9.86e-10 | 135 | 50 | 7 | 28675934 | |
| Pubmed | 6.03e-09 | 175 | 50 | 7 | 28071719 | ||
| Pubmed | Physical mapping of mouse collagen genes on chromosome 10 by high-resolution FISH. | 2.79e-08 | 5 | 50 | 3 | 11331940 | |
| Pubmed | Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. | 9.75e-08 | 7 | 50 | 3 | 9334230 | |
| Pubmed | 1.49e-07 | 167 | 50 | 6 | 22159717 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 2.92e-07 | 97 | 50 | 5 | 27559042 | |
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 3.33e-07 | 10 | 50 | 3 | 15345741 | |
| Pubmed | 5.74e-07 | 210 | 50 | 6 | 16537572 | ||
| Pubmed | 8.29e-07 | 50 | 50 | 4 | 23658023 | ||
| Pubmed | 1.55e-06 | 16 | 50 | 3 | 16880404 | ||
| Pubmed | Genetic loci that control vascular endothelial growth factor-induced angiogenesis. | 1.87e-06 | 17 | 50 | 3 | 12958152 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 1.98e-06 | 62 | 50 | 4 | 28344315 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 33982770 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 12087094 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 20809954 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 27377666 | ||
| Pubmed | Rhox homeobox gene cluster: recent duplication of three family members. | 2.03e-06 | 2 | 50 | 2 | 16496311 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 22694764 | ||
| Pubmed | Ullrich disease due to deficiency of collagen VI in the sarcolemma. | 2.03e-06 | 2 | 50 | 2 | 14981181 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 6852033 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 12374585 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 7836472 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 19386896 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 8830784 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 38481472 | ||
| Pubmed | Novel mutations in collagen VI genes: expansion of the Bethlem myopathy phenotype. | 2.03e-06 | 2 | 50 | 2 | 11865138 | |
| Pubmed | Identification of a tandem duplicated array in the Rhox alpha locus on mouse chromosome X. | 2.03e-06 | 2 | 50 | 2 | 16465597 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 8981332 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 1765372 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 2551668 | ||
| Pubmed | Functional Roles of Complexin 3 and Complexin 4 at Mouse Photoreceptor Ribbon Synapses. | 2.03e-06 | 2 | 50 | 2 | 27335398 | |
| Pubmed | Cloning and characterization of the 5'-flanking region of the Ehox gene. | 2.03e-06 | 2 | 50 | 2 | 16414020 | |
| Pubmed | Insulation of the ubiquitous Rxrb promoter from the cartilage-specific adjacent gene, Col11a2. | 2.03e-06 | 2 | 50 | 2 | 18682388 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 19309692 | ||
| Pubmed | 2.25e-06 | 64 | 50 | 4 | 22261194 | ||
| Pubmed | 2.79e-06 | 153 | 50 | 5 | 25037231 | ||
| Pubmed | Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variability. | 6.07e-06 | 3 | 50 | 2 | 25204870 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 8168508 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 7780011 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 18077458 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 20301676 | ||
| Pubmed | Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures. | 6.07e-06 | 3 | 50 | 2 | 8782832 | |
| Pubmed | Collagen VI involvement in Ullrich syndrome: a clinical, genetic, and immunohistochemical study. | 6.07e-06 | 3 | 50 | 2 | 12011280 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 21459131 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 36982625 | ||
| Pubmed | Amino acid sequence of the triple-helical domain of human collagen type VI. | 6.07e-06 | 3 | 50 | 2 | 3198591 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 22583932 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 8662089 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 12840783 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 3665927 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 8489506 | ||
| Pubmed | Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance. | 6.07e-06 | 3 | 50 | 2 | 18366090 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 18562707 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 24443028 | ||
| Pubmed | Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. | 6.07e-06 | 3 | 50 | 2 | 15563506 | |
| Pubmed | Spatial and temporal changes of type VI collagen expression during mouse development. | 6.07e-06 | 3 | 50 | 2 | 8853993 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 24801232 | ||
| Pubmed | Expression of type VI collagen in the developing mouse heart. | 6.07e-06 | 3 | 50 | 2 | 9520112 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 16141002 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 32053901 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 17602442 | ||
| Pubmed | Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen. | 6.07e-06 | 3 | 50 | 2 | 3348212 | |
| Pubmed | Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis. | 6.29e-06 | 25 | 50 | 3 | 19373938 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 7.36e-06 | 86 | 50 | 4 | 28327460 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 18761340 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 1544908 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 25692331 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 8806434 | ||
| Pubmed | Targeted next-generation sequencing reveals multiple deleterious variants in OPLL-associated genes. | 1.21e-05 | 4 | 50 | 2 | 27246988 | |
| Pubmed | Deficiency of tenascin-X causes a decrease in the level of expression of type VI collagen. | 1.21e-05 | 4 | 50 | 2 | 15194424 | |
| Pubmed | Complexin-I is required for high-fidelity transmission at the endbulb of Held auditory synapse. | 1.21e-05 | 4 | 50 | 2 | 19553439 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 15707895 | ||
| Pubmed | 1.35e-05 | 32 | 50 | 3 | 23154389 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 1.39e-05 | 101 | 50 | 4 | 20551380 | |
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 9524110 | ||
| Pubmed | Expression of a novel homeobox gene Ehox in trophoblast stem cells and pharyngeal pouch endoderm. | 2.02e-05 | 5 | 50 | 2 | 14648851 | |
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 1837533 | ||
| Pubmed | The expanded collagen VI family: new chains and new questions. | 2.02e-05 | 5 | 50 | 2 | 23869615 | |
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 10722718 | ||
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 8812475 | ||
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 11956183 | ||
| Pubmed | Developmental regulation of biglycan expression in muscle and tendon. | 3.03e-05 | 6 | 50 | 2 | 16810681 | |
| Pubmed | HSPG2 MRPL20 FOXQ1 RBM33 DHX37 FUBP1 EIF4G1 HADHA DBN1 RREB1 | 3.04e-05 | 1429 | 50 | 10 | 35140242 | |
| Pubmed | Three novel collagen VI chains with high homology to the alpha3 chain. | 4.23e-05 | 7 | 50 | 2 | 18276594 | |
| Pubmed | Structurally and functionally unique complexins at retinal ribbon synapses. | 4.23e-05 | 7 | 50 | 2 | 15911881 | |
| Pubmed | Premature aggregation of type IV collagen and early lethality in lysyl hydroxylase 3 null mice. | 4.23e-05 | 7 | 50 | 2 | 15377789 | |
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 12242711 | ||
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 8299717 | ||
| Pubmed | Three novel collagen VI chains, alpha4(VI), alpha5(VI), and alpha6(VI). | 4.23e-05 | 7 | 50 | 2 | 18400749 | |
| Pubmed | 3D Mapping Reveals a Complex and Transient Interstitial Matrix During Murine Kidney Development. | 5.64e-05 | 8 | 50 | 2 | 33875569 | |
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 5.64e-05 | 8 | 50 | 2 | 20059976 | |
| Pubmed | Fras1 deficiency results in cryptophthalmos, renal agenesis and blebbed phenotype in mice. | 5.64e-05 | 8 | 50 | 2 | 12766770 | |
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 31600777 | ||
| Pubmed | 5.91e-05 | 146 | 50 | 4 | 27068509 | ||
| Pubmed | Ctip2/Bcl11b controls ameloblast formation during mammalian odontogenesis. | 7.25e-05 | 9 | 50 | 2 | 19251658 | |
| Pubmed | 9.05e-05 | 10 | 50 | 2 | 9136074 | ||
| Pubmed | Generation of a conditionally null allele of the laminin alpha1 gene. | 9.05e-05 | 10 | 50 | 2 | 16100707 | |
| Pubmed | 9.05e-05 | 10 | 50 | 2 | 21972064 | ||
| Pubmed | 9.05e-05 | 10 | 50 | 2 | 9184108 | ||
| Pubmed | 9.05e-05 | 10 | 50 | 2 | 38843837 | ||
| Interaction | COL9A1 interactions | 3.80e-06 | 13 | 49 | 3 | int:COL9A1 | |
| Interaction | PLOD3 interactions | 5.22e-06 | 183 | 49 | 6 | int:PLOD3 | |
| Interaction | LAIR2 interactions | 6.03e-06 | 49 | 49 | 4 | int:LAIR2 | |
| Interaction | COLGALT2 interactions | 2.11e-05 | 67 | 49 | 4 | int:COLGALT2 | |
| Interaction | PRG2 interactions | 6.37e-05 | 285 | 49 | 6 | int:PRG2 | |
| Interaction | COLQ interactions | 7.00e-05 | 33 | 49 | 3 | int:COLQ | |
| Interaction | C1QTNF9 interactions | 9.90e-05 | 37 | 49 | 3 | int:C1QTNF9 | |
| Cytoband | 6p25 | 1.38e-04 | 16 | 50 | 2 | 6p25 | |
| Cytoband | Xq24 | 2.24e-03 | 64 | 50 | 2 | Xq24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq24 | 3.57e-03 | 81 | 50 | 2 | chrXq24 | |
| GeneFamily | Collagens | 2.73e-12 | 46 | 35 | 7 | 490 | |
| Coexpression | NABA_COLLAGENS | 1.81e-12 | 43 | 50 | 7 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 2.15e-12 | 44 | 50 | 7 | M3005 | |
| Coexpression | NABA_CORE_MATRISOME | 4.22e-08 | 270 | 50 | 8 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 4.86e-08 | 275 | 50 | 8 | M5884 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 4.60e-07 | 33 | 50 | 4 | M9167 | |
| Coexpression | HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_DN | 5.87e-07 | 35 | 50 | 4 | M40938 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.02e-06 | 40 | 50 | 4 | M5887 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 7.28e-06 | 20 | 50 | 3 | MM17053 | |
| Coexpression | GU_PDEF_TARGETS_UP | 1.04e-05 | 71 | 50 | 4 | M3955 | |
| Coexpression | NABA_MATRISOME | COL4A2 HSPG2 COL6A1 COL6A2 COL11A2 SULF2 COL13A1 COL5A3 COL22A1 MMP15 | 1.71e-05 | 1008 | 50 | 10 | MM17056 |
| Coexpression | NABA_MATRISOME | COL4A2 HSPG2 COL6A1 COL6A2 COL11A2 SULF2 COL13A1 COL5A3 COL22A1 MMP15 | 2.00e-05 | 1026 | 50 | 10 | M5889 |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 2.30e-05 | 29 | 50 | 3 | MM17055 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 3.96e-05 | 493 | 50 | 7 | M19391 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 4.61e-05 | 505 | 50 | 7 | M39167 | |
| Coexpression | DITTMER_PTHLH_TARGETS_UP | 6.47e-05 | 113 | 50 | 4 | M11090 | |
| Coexpression | BURTON_ADIPOGENESIS_4 | 8.76e-05 | 45 | 50 | 3 | M1605 | |
| Coexpression | BURTON_ADIPOGENESIS_4 | 9.36e-05 | 46 | 50 | 3 | MM1187 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 1.94e-04 | 11 | 50 | 2 | M47997 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_NKT2_CELL | 2.33e-04 | 12 | 50 | 2 | M45774 | |
| Coexpression | VERHAAK_GLIOBLASTOMA_PRONEURAL | 3.63e-04 | 177 | 50 | 4 | M2115 | |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 3.69e-04 | 15 | 50 | 2 | MM402 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FAP_CELLS | 3.79e-04 | 179 | 50 | 4 | M41745 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON | 4.21e-04 | 16 | 50 | 2 | M5718 | |
| Coexpression | CYCLIN_D1_UP.V1_UP | 4.47e-04 | 187 | 50 | 4 | M2654 | |
| Coexpression | GSE22045_TREG_VS_TCONV_UP | 4.65e-04 | 189 | 50 | 4 | M4400 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 4.66e-04 | 79 | 50 | 3 | M18400 | |
| Coexpression | KANG_AR_TARGETS_UP | 4.76e-04 | 17 | 50 | 2 | MM1297 | |
| Coexpression | KANG_AR_TARGETS_UP | 4.76e-04 | 17 | 50 | 2 | M2223 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 4.76e-04 | 17 | 50 | 2 | M47995 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 4.84e-04 | 80 | 50 | 3 | MM1285 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 5.13e-04 | 194 | 50 | 4 | M39122 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_0.5H_BMDC_UP | 5.65e-04 | 199 | 50 | 4 | M3932 | |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP | 5.65e-04 | 199 | 50 | 4 | M9255 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_20H_UP | 5.76e-04 | 200 | 50 | 4 | M9646 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_UP | 5.76e-04 | 200 | 50 | 4 | M9649 | |
| Coexpression | GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN | 5.76e-04 | 200 | 50 | 4 | M5286 | |
| Coexpression | GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_DN | 5.76e-04 | 200 | 50 | 4 | M3575 | |
| Coexpression | GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_DN | 5.76e-04 | 200 | 50 | 4 | M7850 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_DN | 5.76e-04 | 200 | 50 | 4 | M9933 | |
| Coexpression | GSE17721_0.5H_VS_4H_POLYIC_BMDC_UP | 5.76e-04 | 200 | 50 | 4 | M4089 | |
| Coexpression | GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_UP | 5.76e-04 | 200 | 50 | 4 | M7207 | |
| Coexpression | GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_DN | 5.76e-04 | 200 | 50 | 4 | M9262 | |
| Coexpression | GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN | 5.76e-04 | 200 | 50 | 4 | M6193 | |
| Coexpression | GSE22886_NEUTROPHIL_VS_DC_DN | 5.76e-04 | 200 | 50 | 4 | M4465 | |
| Coexpression | LAMB_CCND1_TARGETS | 6.63e-04 | 20 | 50 | 2 | M2935 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 7.03e-04 | 211 | 50 | 4 | M12225 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL | 7.29e-04 | 375 | 50 | 5 | M45799 | |
| Coexpression | JACKSON_DNMT1_TARGETS_DN | 7.32e-04 | 21 | 50 | 2 | MM1196 | |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_DN | 7.75e-04 | 94 | 50 | 3 | M2580 | |
| Coexpression | NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER | 7.75e-04 | 94 | 50 | 3 | M18108 | |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_DN | 7.99e-04 | 95 | 50 | 3 | MM1328 | |
| Coexpression | MURATA_VIRULENCE_OF_H_PILORI | 8.04e-04 | 22 | 50 | 2 | M18608 | |
| Coexpression | JACKSON_DNMT1_TARGETS_DN | 8.04e-04 | 22 | 50 | 2 | M1627 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.18e-08 | 180 | 50 | 6 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class | 6.92e-08 | 189 | 50 | 6 | 4178be3292ff4a8a1d8098f638d4b8d15164d2c6 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-08 | 192 | 50 | 6 | 2d9e2262f1342fe17735f21f733c029d1275e955 | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.83e-08 | 193 | 50 | 6 | 3316d6a39abb6a518d45b846254325fc7a8b2035 | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.83e-08 | 193 | 50 | 6 | e787e618f6e8a1e22be366ce606bf78831b60a90 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.11e-08 | 198 | 50 | 6 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.11e-08 | 198 | 50 | 6 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.11e-08 | 198 | 50 | 6 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.66e-08 | 200 | 50 | 6 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.66e-08 | 200 | 50 | 6 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.64e-07 | 159 | 50 | 5 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-06 | 167 | 50 | 5 | 805129f887078340b260aa136b0ba19f2bd6ea03 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-06 | 167 | 50 | 5 | 31cf8bf2eb523f6e7e319620648ff37fc09e2601 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-06 | 167 | 50 | 5 | 3acb18428d1d33ad430c2fd031b1a91baee3c01d | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.46e-06 | 173 | 50 | 5 | 789ab8b2709f4b8728e3733bc72744e9d92ea5ea | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.87e-06 | 182 | 50 | 5 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-06 | 185 | 50 | 5 | ca69499ba8c39b7ed6717d05685d6f70066a77bd | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-06 | 186 | 50 | 5 | 6f88b68735d0f7c9904eb8413e6007910d556185 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.20e-06 | 188 | 50 | 5 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.20e-06 | 188 | 50 | 5 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 188 | 50 | 5 | 7191087d8754f5e8700e3d744cd920ee26db1e57 | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.25e-06 | 189 | 50 | 5 | 46c5b975fb9d33017f2d9b7770d45a8bdf95baa2 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-06 | 190 | 50 | 5 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-06 | 190 | 50 | 5 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-06 | 190 | 50 | 5 | 947807863a9b247c301c6cf63d6fd5a2c8018e66 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-06 | 190 | 50 | 5 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-06 | 190 | 50 | 5 | 47077579496c5340e99f61499427a3a36b566da3 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.37e-06 | 191 | 50 | 5 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-06 | 192 | 50 | 5 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-06 | 192 | 50 | 5 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-06 | 192 | 50 | 5 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-06 | 192 | 50 | 5 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-06 | 192 | 50 | 5 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-06 | 192 | 50 | 5 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-06 | 193 | 50 | 5 | eba3c70701b051bc1ed1f4db9270cb27a77ffc3e | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-06 | 193 | 50 | 5 | 49600db68ed65cafc67bd45a285b364e4f5f88af | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-06 | 193 | 50 | 5 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-06 | 194 | 50 | 5 | 5d30d3d41d5f19cdf3077cc609aa2738762cb8c5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.63e-06 | 195 | 50 | 5 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.63e-06 | 195 | 50 | 5 | bff7685784688425bebd78b0f284a6d4475a9415 | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.63e-06 | 195 | 50 | 5 | aed243418cdb5df4563a7b935c1ecbd744590901 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-06 | 195 | 50 | 5 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.69e-06 | 196 | 50 | 5 | 40e6900a0d56088a40d37ec312f53207ea952602 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.69e-06 | 196 | 50 | 5 | 7acd782a587b7d331517f60daa8b5c2177bedfc7 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.69e-06 | 196 | 50 | 5 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-06 | 196 | 50 | 5 | 0dfa2dc1ec527d40005614c00ed0e5f3a566c2e2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.69e-06 | 196 | 50 | 5 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | droplet-Liver-LIVER-NPC|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-06 | 196 | 50 | 5 | a3513c91afdc2d363e1c57071ae2399f9b7e6263 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.69e-06 | 196 | 50 | 5 | 0b247cf981981ae61aca5de82ef687e8d783c9ef | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.69e-06 | 196 | 50 | 5 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.76e-06 | 197 | 50 | 5 | 983502a99e6d59bb36225b0246a9990604de1a01 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes-Pericyte|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.76e-06 | 197 | 50 | 5 | 452be45f4aac8459dd860493171f5f715368d663 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.83e-06 | 198 | 50 | 5 | 63f7d25201613bd3404c28fb936954190bca91d3 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.83e-06 | 198 | 50 | 5 | a73534b6ca202c277a70a52281d5b97a3e6cb8ef | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.83e-06 | 198 | 50 | 5 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.83e-06 | 198 | 50 | 5 | d1e1bdd36c84e1bac21ba137f018defe98456a8c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.83e-06 | 198 | 50 | 5 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.83e-06 | 198 | 50 | 5 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-06 | 198 | 50 | 5 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-06 | 198 | 50 | 5 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.90e-06 | 199 | 50 | 5 | 7b1b3b108d817fb3b50a710c3146b30bcf9c2f6b | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-06 | 199 | 50 | 5 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.90e-06 | 199 | 50 | 5 | f2ad641f36c577ff7019e88ad6b73ed7e46d8c74 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-06 | 199 | 50 | 5 | 3d8c76e3d05acf72a35ca755b51579fc3ae63562 | |
| ToppCell | distal-mesenchymal-Pericyte-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.90e-06 | 199 | 50 | 5 | e72ac7a00405cde06293d7adac7dc40eb0cf87ba | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.97e-06 | 200 | 50 | 5 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.97e-06 | 200 | 50 | 5 | cf883ba5dbe6350b93142d625a52b25ff2a8bb63 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.97e-06 | 200 | 50 | 5 | 3da9441c0f1e242f0d195de47ecd4c24dfdca232 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.97e-06 | 200 | 50 | 5 | eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.97e-06 | 200 | 50 | 5 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | distal-1-mesenchymal-Pericyte|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.97e-06 | 200 | 50 | 5 | ff205afda57b9267016f0c937445da1b0266af9b | |
| ToppCell | Control-Control-Lymphocyte-T/NK-MAIT|Control / Disease, condition lineage and cell class | 2.97e-06 | 200 | 50 | 5 | 888a8045e0457cd9d0c570360cca20a6efb44f13 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Dcn-Endothelial_Tip.Dcn.Nenf_(Nenf)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.23e-06 | 114 | 50 | 4 | 7be16e7f7b9c9dbd68933ace3b7f8f661bed41a7 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Dcn|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.23e-06 | 114 | 50 | 4 | f4bdfc47418d22a49e0c4a6c3bd0663e15fb53bb | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.22e-05 | 126 | 50 | 4 | f1f24b06d301c266226d1a59dd28585f5ac68f29 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.22e-05 | 126 | 50 | 4 | fe6900eb37e4f09465a1276586c73dd38545fa2a | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.22e-05 | 126 | 50 | 4 | 3d507f829882d043f633db2612b76936e2042445 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.22e-05 | 126 | 50 | 4 | 1ac4cc747e466bc79e33b97608b19ad29a7a6a41 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.22e-05 | 126 | 50 | 4 | 2de551d7a8765afec1da8852727c79fec90f45f8 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.62e-05 | 153 | 50 | 4 | e9c6fb5c41adb6595c66c3a917fe455348279e54 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.62e-05 | 153 | 50 | 4 | b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.62e-05 | 153 | 50 | 4 | 2513edfae62a44e51d3556675a096723194c966c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.90e-05 | 157 | 50 | 4 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 160 | 50 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.12e-05 | 160 | 50 | 4 | 79e833c904c762434993b5ec9d5e3540e695fad3 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 160 | 50 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.52e-05 | 165 | 50 | 4 | 4e13fccd32029e2879e85f8966e582a46c09e4aa | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.78e-05 | 168 | 50 | 4 | af82e07d1eec51fc6530155f37addbce6221885d | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 3.96e-05 | 170 | 50 | 4 | d69c0ea4cb6b204f19d0a5d2164afb42184779ac | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.96e-05 | 170 | 50 | 4 | 7fa022471e14ac8a3bc147c793368a4d56a8e591 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 4.05e-05 | 171 | 50 | 4 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | Healthy/Control-MAIT|World / Disease group and Cell class | 4.05e-05 | 171 | 50 | 4 | 61515114b17816a8f9ef6a57262eb9e977b6ede4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.05e-05 | 171 | 50 | 4 | f648789e6aefe508bb748401bf9b3cd830fb0ddf | |
| ToppCell | Control-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 4.14e-05 | 172 | 50 | 4 | 813d4256b05b66ca11b08cc0026459d79f12c0eb | |
| ToppCell | Healthy/Control-MAIT|Healthy/Control / Disease group and Cell class | 4.24e-05 | 173 | 50 | 4 | 56247c1e07477a8922fe2e3950ae05e2217fd77c | |
| ToppCell | Control-Stromal-Pericyte|Control / Disease state, Lineage and Cell class | 4.33e-05 | 174 | 50 | 4 | 91fc1f1c891f105a91968c22e2de5321c52b439a | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-05 | 174 | 50 | 4 | 68a6ed81e7e1f95b61f7ee20403980fa3a8db4d0 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.43e-05 | 175 | 50 | 4 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-05 | 176 | 50 | 4 | 6b4afd2c9268172063fe5832896bea15e862579e | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-05 | 176 | 50 | 4 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.03e-04 | 50 | 25 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Drug | AC1NMZ1B | 1.48e-08 | 75 | 50 | 6 | CID005034185 | |
| Drug | GK-101 | 1.49e-08 | 36 | 50 | 5 | CID000161853 | |
| Drug | Madecassol | 5.33e-08 | 46 | 50 | 5 | CID000108062 | |
| Drug | d-indobufen | 8.18e-08 | 50 | 50 | 5 | CID000044562 | |
| Drug | ridogrel | 1.00e-07 | 52 | 50 | 5 | CID005362391 | |
| Drug | NSC49633 | 1.10e-07 | 53 | 50 | 5 | CID000023340 | |
| Drug | AC1L1DD6 | 1.24e-07 | 179 | 50 | 7 | CID000002299 | |
| Drug | AC1L1C2F | 1.48e-07 | 110 | 50 | 6 | CID000001711 | |
| Drug | Tranilast sodium | 1.93e-07 | 115 | 50 | 6 | CID000005527 | |
| Drug | AC1LAKND | 2.45e-07 | 62 | 50 | 5 | CID000470146 | |
| Drug | DMSe | 4.37e-07 | 132 | 50 | 6 | CID000020796 | |
| Drug | BAPN | 4.86e-07 | 71 | 50 | 5 | CID000001647 | |
| Drug | malotilate | 4.86e-07 | 71 | 50 | 5 | CID000004006 | |
| Drug | pirfenidone | 5.67e-07 | 138 | 50 | 6 | CID000040632 | |
| Drug | DL-penicillamine | 5.92e-07 | 139 | 50 | 6 | CID000004727 | |
| Drug | strontium ranelate | 7.30e-07 | 77 | 50 | 5 | CID006918182 | |
| Drug | halofuginone lactate | 1.20e-06 | 85 | 50 | 5 | CID000062891 | |
| Drug | hyaluronan | 1.66e-06 | 263 | 50 | 7 | CID000024759 | |
| Drug | 4-hydroxyproline | 1.68e-06 | 91 | 50 | 5 | CID000000825 | |
| Drug | chondroitin sulfate | 3.02e-06 | 413 | 50 | 8 | CID000024766 | |
| Drug | ticlopidine | 3.10e-06 | 103 | 50 | 5 | CID000005472 | |
| Drug | hydroxylysine | 4.09e-06 | 109 | 50 | 5 | CID000001029 | |
| Drug | PPACK | 4.88e-06 | 113 | 50 | 5 | CID003036757 | |
| Drug | AC1L9732 | 5.10e-06 | 114 | 50 | 5 | CID000439300 | |
| Drug | Selara | 8.00e-06 | 125 | 50 | 5 | CID000150310 | |
| Drug | PCR 4099 | 1.34e-05 | 139 | 50 | 5 | CID000002806 | |
| Drug | candesartan cilexetil | 1.64e-05 | 145 | 50 | 5 | CID000002540 | |
| Drug | 2-amino-4,6-dinitrotoluene | 1.70e-05 | 70 | 50 | 4 | ctd:C035208 | |
| Drug | prostacyclin sodium salt | 1.75e-05 | 250 | 50 | 6 | CID000000159 | |
| Drug | losartan | 1.78e-05 | 378 | 50 | 7 | CID000003961 | |
| Drug | L-3,4-dehydroproline | 2.00e-05 | 73 | 50 | 4 | CID000094284 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 2.80e-05 | 162 | 50 | 5 | CID000072363 | |
| Drug | khellin | 3.63e-05 | 171 | 50 | 5 | CID000003828 | |
| Drug | Y-27632 | 4.95e-05 | 444 | 50 | 7 | CID000005711 | |
| Drug | AC1L9HPX | 4.99e-05 | 92 | 50 | 4 | CID000445279 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 5.85e-05 | 189 | 50 | 5 | CID000001413 | |
| Drug | foscarnet | 6.00e-05 | 190 | 50 | 5 | CID000003414 | |
| Drug | (2s,5s)-5-Carboxymethylproline | 6.26e-05 | 314 | 50 | 6 | CID000447989 | |
| Drug | (d,l)-Tetrahydroberberine [522-97-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 7.12e-05 | 197 | 50 | 5 | 4138_UP | |
| Drug | AC1L18QD | 7.56e-05 | 325 | 50 | 6 | CID000000213 | |
| Drug | AC1L1KMJ | 7.67e-05 | 476 | 50 | 7 | CID000030956 | |
| Drug | dermatan sulfate | 1.20e-04 | 220 | 50 | 5 | CID000032756 | |
| Drug | Pcme | 1.31e-04 | 8 | 50 | 2 | CID000169849 | |
| Drug | AC1Q6PCP | 1.47e-04 | 230 | 50 | 5 | CID000005267 | |
| Drug | 2,3-pentanedione | 1.85e-04 | 129 | 50 | 4 | ctd:C013186 | |
| Drug | testosterone enanthate | 2.46e-04 | 575 | 50 | 7 | ctd:C004648 | |
| Drug | LS-63783 | 3.37e-04 | 804 | 50 | 8 | CID000000231 | |
| Drug | GW2331 | 3.63e-04 | 13 | 50 | 2 | CID000657048 | |
| Disease | Bethlem myopathy (is_implicated_in) | 1.49e-05 | 4 | 47 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy | 1.49e-05 | 4 | 47 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 1.49e-05 | 4 | 47 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 1.49e-05 | 4 | 47 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 1.49e-05 | 4 | 47 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | MRNA-decapping enzyme 1A measurement | 1.49e-05 | 4 | 47 | 2 | EFO_0802757 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 1.49e-05 | 4 | 47 | 2 | C0410179 | |
| Disease | retinal detachment, retinal break | 2.39e-05 | 35 | 47 | 3 | EFO_0005773, EFO_0010698 | |
| Disease | RASopathy (implicated_via_orthology) | 8.88e-05 | 9 | 47 | 2 | DOID:0080690 (implicated_via_orthology) | |
| Disease | peak expiratory flow | 1.34e-04 | 498 | 47 | 6 | EFO_0009718 | |
| Disease | snoring measurement | 3.30e-04 | 84 | 47 | 3 | EFO_0008341 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 4.17e-04 | 19 | 47 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Early Pregnancy Loss | 7.06e-04 | 109 | 47 | 3 | C3830362 | |
| Disease | Miscarriage | 7.06e-04 | 109 | 47 | 3 | C4552766 | |
| Disease | Spontaneous abortion | 7.06e-04 | 109 | 47 | 3 | C0000786 | |
| Disease | Abortion, Tubal | 7.06e-04 | 109 | 47 | 3 | C0000822 | |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 1.12e-03 | 31 | 47 | 2 | DOID:3328 (biomarker_via_orthology) | |
| Disease | white matter hyperintensity measurement | 1.36e-03 | 302 | 47 | 4 | EFO_0005665 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KGDDGSPGRDGLDGF | 571 | P08572 | |
| DDFEKISELGAGNGG | 66 | Q02750 | |
| GASGGAGAGDDDFDQ | 6 | Q96EV2 | |
| GDDLGSGDLGSGDFQ | 66 | P98160 | |
| AGEGAGGEAGADKEQ | 366 | Q92806 | |
| EGPGDSVKFEGGEDA | 521 | Q9NSK0 | |
| GAGGLAAGKASGADE | 221 | Q96JE9 | |
| GAGDVGKEALSGGEA | 236 | Q96T17 | |
| HAGGGGDELGKPDDD | 121 | Q5TGJ6 | |
| GGGGGGVNDAFKDAL | 21 | Q96AE4 | |
| DGDGDFGAGVNKDGG | 596 | P51511 | |
| GEKGEDGFPGFKGDI | 736 | P13942 | |
| DGFPGFKGDIGVKGD | 741 | P13942 | |
| DGSDDLKLAASGEGG | 36 | Q16643 | |
| FGEELAGEGKSEVGG | 21 | A4D2B8 | |
| AKSDAGLVGGGEDGD | 1406 | P23471 | |
| LTGSLGGGEDKGDGD | 16 | Q8WVH0 | |
| GGGEDKGDGDKSAAE | 21 | Q8WVH0 | |
| LGFGGGSEENKEEGG | 16 | Q7Z7G2 | |
| GAFLKRAAGGGDAGD | 621 | Q9C0K0 | |
| GGGGFSDKDLEDIVG | 141 | Q8TCZ2 | |
| AFGLKGEKGEPGADG | 366 | P12109 | |
| GVPGFKGEKGEFGAD | 301 | P12110 | |
| GKDGERGEKGAAGEE | 946 | Q8NFW1 | |
| GEAGEAGEAESEKGG | 466 | Q04637 | |
| GGEAEAPAAEGGKDE | 181 | P29966 | |
| APAAEGGKDEAAGGA | 186 | P29966 | |
| EDLGKVFGERFGGGN | 601 | P40939 | |
| AGLDGAKGEKGFQGE | 591 | Q5TAT6 | |
| DLDLDLGDGGQDGGE | 566 | Q8IY37 | |
| GEDGFPGFKGDVGLK | 731 | P25940 | |
| AEGASADKLGAADGG | 506 | B7ZC32 | |
| ADKLGAADGGDGKAG | 511 | B7ZC32 | |
| AHGDKQGSDLEGAGG | 11 | Q9C009 | |
| GGGAAGGAEDLAELD | 91 | Q13253 | |
| AKLAGGDSDGGELLG | 81 | Q9Y4I5 | |
| GLGAAVGKEAEGAGE | 26 | O95219 | |
| EGFAAALGDGKEPEG | 126 | Q9BYC9 | |
| GDFIGNLEGLNDGGD | 676 | A5PKW4 | |
| AGGVFLNGGKTDDEG | 266 | Q5T2S8 | |
| EGDDGGIFPKDGSGD | 186 | Q08752 | |
| QGGEEKDGGGEEKDG | 66 | P0C7M4 | |
| EEAAGAASGEGKAGG | 341 | Q3SY56 | |
| RGKDKDGDGEGAGGA | 281 | P28702 | |
| DFKLAEGDGEAGAGG | 1371 | Q92766 | |
| AAGGGAKAEADGGYE | 606 | Q6T4P5 | |
| DGSEADRGKLDFGSG | 21 | Q9Y5S1 | |
| QGGEEKDGGGEEKDG | 66 | Q9BQY4 | |
| GKFGEEIGSDQFGGC | 2426 | Q86WI1 | |
| AQDGAGGEEEKAEGG | 736 | A7E2V4 | |
| AAFAGGDGDGDQAAG | 76 | P0DKB5 | |
| SEGAGGGLLEEGDKA | 206 | Q5JPB2 | |
| GSDGSQEDAKEDGFG | 226 | Q9Y462 | |
| DKDGGDFSGTGGLPD | 576 | Q8IWU5 |